Avet Pharmaceuticals, Inc. recalls Losartan Potassium Tablets USP 100 mg, supplied in a) 30 count (NDC 23155-646-03, b) 90 count (NDC 23155-646-09) and
FDA-confirmed impurity in Avet Losartan Potassium Tablets 100mg may exceed safe levels. Recalled 30-count and 90-count bottles. Stop using immediately.
Stop using this now
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level
Contact the company & request your remedy
What happened, in plain English
Avet Pharmaceuticals is recalling Losartan Potassium Tablets 100mg due to FDA-confirmed impurities that could exceed safe levels. This affects specific bottle sizes sold in the US. The impurity may pose health risks if taken regularly. Read more at govinfonow.com/recall/37209-avet-losartan-tablets-recall-impurity-risk-in-100mg-dose.
Source Summary by GovInfoNow · govinfonow.com/recall/37209-avet-losartan-tablets-recall-impurity-risk-in-100mg-dose · Updated October 5, 2026 · FDA enforcement record: FDA #D-1104-2020
Cite this page
“Avet Losartan Tablets Recall: Impurity Risk in 100mg Dose.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37209-avet-losartan-tablets-recall-impurity-risk-in-100mg-dose. Based on FDA recall #D-1104-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1104-2020%22&limit=1).
Why it’s dangerous
The FDA found an impurity called N-Methylnitrosobutyric acid (NMBA) in the tablets. This impurity is present above the safe daily intake level, which could cause health issues with regular use.
Who’s affected
People who have the recalled 30-count or 90-count bottles of Losartan Potassium Tablets 100mg. Those taking this medication for blood pressure should be most at risk.
How to tell if you have this one
Check for bottles labeled 'Losartan Potassium Tablets USP 100 mg' with either 30-count (NDC 23155-646-03) or 90-count (NDC 23155-646-09) packaging. These are prescription-only products.
- Brand
Avet Pharmaceuticals- Category
Drug
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
Nationwide
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-1103-2020 | Losartan Potassium Tablets USP 50 mg, a) 30 count (NDC 23155-645-03), b) 90 count (NDC 23155-645-09) and c) 1000 count (NDC 23155-645-10) bottles, Rx only, Manufactured by: Vivimed Life Sciences Private Limited, Tamil Nadu, India, Manufactured for: Heritage Pharmaceutical Inc., East Brunswick, NJ 08816 NDC 23155-645-09; a) CL018008A, exp Mar 2020; b) CL018008B, exp Mar 2020; c) CL018009A, exp Mar 2020 | a) 2,904; b) 14,316; c) 1,368 bottles |
| D-1104-2020 | Losartan Potassium Tablets USP 100 mg, supplied in a) 30 count (NDC 23155-646-03, b) 90 count (NDC 23155-646-09) and 1000 count (NDC 23155-646-10) bottles, Rx only, Manufactured by: Vivimed Life Sciences Private Limited, Tamil Nadu, India Manufactured for: Heritage Pharmaceutical Inc., East Brunswick, NJ 08816; a) CL018022B, exp Apr 2020 b) CL018010A Mar 2020; CL018017B, CL018018A exp Apr 2020 c) CL018011A, CL018012A exp Mar 2020; CL018013A, CL018015A, CL018016A, CL018017A, exp Apr 2020 | a) 12,168; b) 17,196; c) 3,890 |
What to do — step by step
Stop Using Immediately
Discard all recalled tablets and do not take them.
Questions people ask
Is this impurity dangerous?
Yes, the FDA confirmed the impurity (NMBA) is present above the safe daily intake level, which could cause health issues with regular use.
What should I do if I have the recalled product?
Discard the tablets immediately and do not take them. Contact your doctor for alternative medication options.
Are there any other products affected?
No, only the 30-count and 90-count bottles of Losartan Potassium Tablets 100mg are recalled.
Contact Avet Pharmaceuticals
We’ve drafted a message you can send Avet Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-1104-2020 — Avet Pharmaceuticals Avet Pharmaceuticals Hello, I own a Avet Pharmaceuticals that is covered by recall D-1104-2020 from Avet Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1104-2020 (March 26, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1104-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.